Mercury General is rebuilding its capital quickly, despite the huge CAT losses caused by LA Wildfires. Read why I remain ...

FY25 revenue surged 27%, fueled by B2B growth and new tools. Merchant solutions segment contributed 74% of revenue. See more ...

Gartner's key segments like Global Technology Sales and Global Business Sales show solid demand. Read why I maintain a Buy ...

Discover JPIB, JPMorgan's global bond ETF with a 6.7% yield, low volatility, and USD focus. Diversify your portfolio for ...

Lucid outpaces expectations with Q1'25 growth in deliveries and revenue. Read why I maintain a cautious Hold rating on LCID ...

Porch Group, Inc.'s shift to a fee-based insurance model has driven record profitability, improved margins, and reduced ...

As IREN transitions to U.S. GAAP reporting from 1 July 2025, the accounting for the convertible notes, capped call and prepaid forward will be reassessed in line with applicable accounting standards.

Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...

UnitedHealth Group's stock has plunged nearly 50% due to the CEO resignation, withdrawal of guidance, and ongoing legal ...

CAE stock is poised for growth with rising aerospace demand, strong earnings, minimal tariff risks, and a 21%-41% ...

COMPASS Pathways focuses on developing COMP360 psilocybin for treatment-resistant depression. Click here to read an analysis ...

Capital Southwest (CSWC) turned in fiscal Q4 earnings in line with the consensus estimate even as its total investment income ...